Akorn Operating Company LLC. 2023. Olopatadine product label. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f42d26f8-c583-411b-b17f-b3ca9eaba7a2. Accessed 30 September 2024. …
The Baby Blog
About Our Baby Blog
Every person wants to know what’s best for their baby, especially when it comes to knowing how to minimize exposure risks. Our relatable stories are packed with practical information from our rotating staff of MotherToBaby expert bloggers. Whatever topic you’re looking for, our blogs will provide you a great foundation to learn more.
Guaifenesin
Selected References: Aselton P, et al. 1985. First-trimester drug use and congenital disorders. Obstet Gynecol 65:451-5. Check J, et al. 1982. Improvement of cervical mucus factor with guaifenesin. Fertility and Sterility, 37(5): 707-708. Briggs GG, et al. 2017. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 11th ed. Cao Y, et al. 2021. Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case-control …
Dimethyl Fumarate
Selected References: Amato MP, et al. 2015. Fertility, pregnancy and childbirth in patients with multiple sclerosis: Impact of disease-modifying drugs. CNS Drugs. 29:207–220. Andersen JB, et al. 2023. Pregnancy outcomes after early fetal exposure to injectable first-line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis. Eur J Neurol 30(1):162-171. Bridel C, et al. 2014. Update on multiple sclerosis treatments. Swiss Med Wkly. 144:w14012. Ciplea …
Losartan
Selected References: Alwan S, et al. 2005. Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Teratol. 73:123-130. Bass JK, Faix RG. 2006. Gestational Therapy with an Angiotensin II Receptor Antagonist and Transient Renal Failure in a Premature Infant. Am J Perinatol. 23:313-318. Centers for Disease Control and Prevention. 2020. Facts about craniosynostosis. Centers for Disease Control and Prevention. Available oneline at …
Clorazepate
Selected References: Athinarayanan P, et al. 1976. Chlordizaepoxide withdrawal in the neonate. Am J Obstet Gynecol 124:212-3. Brunaud M, et al. 1970. Pharmacological, toxicological, and teratological studies on dipotassium-7-chloro-3-carboxy-1, 3-dihydro-2, 2-dihydroxy-5-phenyl-2H-1, 4-benzodiazepine-cloraz-epate (dipotassium chlorazepate, 4306 CB), a new tranquilizer. Arzneim Forsch 20:123-5. Cole AP, Hailey DM: Diazepam and active metabolites in breast milk and their transfer to the …
